×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Veterinary Medicine Manufacturing Market

ID: MRFR/HC/20195-HCR
128 Pages
Rahul Gotadki
October 2025

India Veterinary Medicine Manufacturing Market Research Report Information By Product (Drugs (Anti-infective, Anti-inflammatory, Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives (Amino Acids, Antibiotics)), By Animal Type (Companion Animals and Livestock Animals), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, and Online Pharmacies)– India Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Veterinary Medicine Manufacturing Market Infographic
Purchase Options

India Veterinary Medicine Manufacturing Market Summary

As per analysis, the India Veterinary Medicine Market is projected to grow from USD 1.81 Billion in 2024 to USD 3.13 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period (2025 - 2035).

Key Market Trends & Highlights

The India Veterinary Medicine Market is experiencing robust growth driven by rising pet ownership and advancements in veterinary technology.

  • The Therapeutic segment remains the largest, catering primarily to companion animals, which dominate the market.
  • Preventive healthcare is emerging as the fastest-growing segment, reflecting a shift towards proactive animal health management.
  • The livestock segment is witnessing rapid growth, driven by increasing demand for animal protein and sustainable farming practices.
  • Key market drivers include the rise in livestock farming and government initiatives aimed at enhancing animal health awareness.

Market Size & Forecast

2024 Market Size 1.81 (USD Billion)
2035 Market Size 3.13 (USD Billion)
CAGR (2025 - 2035) 5.1%

Major Players

Zoetis (IN), Boehringer Ingelheim (DE), Merck Animal Health (US), Elanco Animal Health (US), Virbac (FR), Heska Corporation (US), Vetoquinol (FR), Indian Immunologicals Limited (IN), Patanjali Ayurved Limited (IN)

India Veterinary Medicine Manufacturing Market Trends

The India Veterinary Medicine Market is currently experiencing a dynamic evolution, driven by a combination of factors including increasing pet ownership, rising awareness of animal health, and advancements in veterinary technology. The growing trend of pet humanization has led to a surge in demand for high-quality veterinary services and products. Additionally, the government of India has been actively promoting animal health initiatives, which further supports the market's expansion. As a result, veterinary practitioners are increasingly adopting innovative treatment methods and preventive care strategies, enhancing the overall quality of animal healthcare in the country. Moreover, the market is witnessing a shift towards preventive healthcare, with pet owners becoming more proactive in seeking regular check-ups and vaccinations for their animals. This trend is likely to be bolstered by the increasing availability of veterinary services in rural areas, where access to healthcare has historically been limited. Furthermore, the rise of e-commerce platforms is facilitating easier access to veterinary medicines and products, thereby contributing to the market's growth. Overall, the India Veterinary Medicine Market appears poised for continued expansion, driven by evolving consumer preferences and supportive government policies.

Rise in Pet Ownership

The trend of increasing pet ownership in India is significantly influencing the veterinary medicine sector. As more households welcome pets, the demand for veterinary services and products is likely to grow. This shift is accompanied by a heightened awareness of animal welfare and health, prompting pet owners to seek regular veterinary care.

Advancements in Veterinary Technology

Technological innovations in veterinary medicine are transforming the landscape of animal healthcare in India. The introduction of advanced diagnostic tools and treatment options is enhancing the capabilities of veterinary practitioners. This trend may lead to improved health outcomes for animals and increased trust in veterinary services.

Focus on Preventive Healthcare

There is a noticeable shift towards preventive healthcare in the India Veterinary Medicine Market. Pet owners are increasingly prioritizing regular check-ups and vaccinations, which is likely to foster a culture of proactive health management. This trend could be further supported by government initiatives aimed at promoting animal health.

India Veterinary Medicine Manufacturing Market Drivers

Increase in Livestock Farming

The India Veterinary Medicine Market is experiencing a notable surge due to the increase in livestock farming. With the growing demand for dairy and meat products, farmers are investing in veterinary services to ensure the health and productivity of their animals. According to recent data, the livestock sector contributes significantly to India's agricultural GDP, accounting for approximately 4.11 percent. This growth in livestock farming necessitates the use of veterinary medicines to prevent diseases and enhance productivity, thereby driving the demand for veterinary services and products. As farmers become more aware of the importance of animal health, the veterinary medicine market is likely to expand further, reflecting a shift towards more sustainable and productive farming practices.

Growth of the Pet Care Industry

The India Veterinary Medicine Market is closely linked to the growth of the pet care industry, which has been expanding rapidly in recent years. With an increasing number of households adopting pets, there is a corresponding rise in the demand for veterinary services and products. The pet care market in India is projected to grow at a CAGR of 20 percent, indicating a robust demand for veterinary medicines, preventive care, and specialized treatments. This growth is further fueled by changing consumer attitudes towards pet ownership, where pets are increasingly viewed as family members. Consequently, the veterinary medicine market is likely to benefit from this trend, as pet owners seek high-quality healthcare solutions for their animals.

Rising Awareness of Animal Health

The India Veterinary Medicine Market is witnessing a transformation driven by the rising awareness of animal health among pet owners and livestock farmers. As the population becomes more educated about the importance of veterinary care, there is a growing demand for preventive healthcare measures, including vaccinations and regular check-ups. This trend is particularly evident in urban areas, where pet ownership is on the rise. Data suggests that the pet care market in India is projected to reach USD 490 million by 2025, indicating a substantial increase in spending on veterinary services. This heightened awareness is likely to propel the veterinary medicine market forward, as consumers seek quality healthcare solutions for their animals.

Government Initiatives and Policies

The India Veterinary Medicine Market is significantly influenced by government initiatives aimed at improving animal health and welfare. The government has implemented various policies to promote veterinary services, including the National Livestock Mission, which focuses on enhancing livestock productivity and health. These initiatives often include subsidies for veterinary medicines and vaccinations, making them more accessible to farmers. Furthermore, the government's emphasis on disease control and prevention, particularly in livestock, has led to increased investments in veterinary infrastructure. As a result, the veterinary medicine market is likely to benefit from these supportive policies, fostering a more robust veterinary healthcare system across the country.

Technological Advancements in Veterinary Medicine

The India Veterinary Medicine Market is being reshaped by technological advancements that enhance the efficiency and effectiveness of veterinary care. Innovations such as telemedicine, diagnostic tools, and advanced treatment options are becoming increasingly available to veterinarians. These technologies not only improve the quality of care but also streamline operations within veterinary practices. For instance, the introduction of mobile veterinary clinics has made it easier for farmers in remote areas to access veterinary services. As these technologies continue to evolve, they are expected to drive growth in the veterinary medicine market, enabling practitioners to provide better care and improve animal health outcomes across India.

Market Segment Insights

By Application: Therapeutic (Largest) vs. Preventive (Fastest-Growing)

In the India Veterinary Medicine Market, the application segment is primarily dominated by therapeutic solutions, which hold the largest share due to their essential role in treating diseases across various animal species. Preventive applications are rapidly gaining traction, reflecting the growing awareness in animal healthcare. This shift is influencing the market landscape as veterinarians and pet owners increasingly prioritize preventive care measures such as vaccinations, parasite control, and wellness programs to minimize future health issues. In terms of growth trends, preventive veterinary medicine is becoming the fastest-growing segment as the focus shifts towards proactive health management for livestock and companion animals. This growth is driven by rising awareness of zoonotic diseases, an increase in pet ownership, and the need for enhanced livestock productivity. Factors such as government initiatives promoting disease prevention in livestock and a move towards higher standards in animal care are fuelling this upward trend.

Therapeutic (Dominant) vs. Diagnostic (Emerging)

Within the India Veterinary Medicine Market, the therapeutic application stands out as the dominant segment, catering extensively to various health conditions in different animal species. Therapeutic solutions are critical for treating infections, chronic conditions, and emergencies, making them indispensable in veterinary practices. On the other hand, the diagnostic segment is viewed as an emerging player in the market. With advancements in veterinary diagnostics, including real-time PCR, imaging technologies, and lab tests, the demand for accurate and quick diagnostic tools is increasing. This shift towards evidence-based veterinary medicine highlights the rising importance of diagnostics to support therapeutic decisions. Together, therapeutic and diagnostic applications are key components driving the evolution of veterinary healthcare in India.

By Animal Type: Companion Animals (Largest) vs. Livestock (Fastest-Growing)

The India Veterinary Medicine Market exhibits a diverse distribution among different animal types. Companion animals lead the market, capturing a significant share due to the increasing trend of pet ownership in urban areas. This segment is characterized by rising spending on pet health and wellness, alongside a growing awareness of veterinary care. In contrast, livestock and poultry segments have also seen substantial market engagement, contributing to the overall expansion of veterinary services alongside stricter health regulations and the push for improved livestock management practices. Growth trends for the animal type segment indicate that while companion animals maintain a robust market presence, the livestock sector is emerging as the fastest-growing area in terms of veterinary medicine demand. Factors such as increased livestock production for dairy and meat, along with government initiatives to enhance veterinary services in rural regions, are driving this growth. Additionally, the rise of disease outbreaks has heightened the focus on livestock health, showcasing the critical role of veterinary medicines in improving animal health across various types.

Companion Animals (Dominant) vs. Livestock (Emerging)

In the India Veterinary Medicine Market, the companion animals segment stands as the dominant force, buoyed by strong consumer trends reflecting rising pet ownership and expenditure on veterinary services. This segment encompasses dogs, cats, and other small pets, with owners increasingly seeking advanced healthcare solutions. Conversely, the livestock segment is emerging significantly, driven by enhanced awareness of animal welfare standards and stricter regulations around meat and dairy production. Livestock farming is shifting towards more sustainable practices, highlighting the need for effective veterinary medicines to support animal health and productivity. The interplay of traditional farming methods with modern veterinary solutions is redefining this segment's landscape.

By Product Type: Pharmaceuticals (Largest) vs. Vaccines (Fastest-Growing)

In the India Veterinary Medicine Market, the 'Product Type' segment shows a diverse distribution among its various categories. Pharmaceuticals hold the largest market share, driven by their wide application in treating a range of animal diseases. Following pharmaceuticals, vaccines are experiencing significant growth as they are essential for disease prevention in livestock and pets, reflecting an increased awareness of animal health and the importance of preventative care. Feed additives and medical devices also contribute to the market, although they take a smaller share compared to the leading segments. The growth trends in this segment are indicative of several factors, including advancements in veterinary science and heightened emphasis on animal welfare. The demand for innovative vaccines and effective pharmaceuticals is spurred by the growing livestock population and changing consumer preferences towards healthier animal production. Additionally, rising investment in veterinary healthcare infrastructure and a shift towards preventive healthcare practices are propelling vaccines to become the fastest-growing product type in the market, further catering to the evolving habits of pet owners and livestock producers.

Pharmaceuticals (Dominant) vs. Diagnostic Kits (Emerging)

Pharmaceuticals have established themselves as the dominant segment in the India Veterinary Medicine Market, with a comprehensive range of products addressing various animal health challenges. They encompass antibiotics, anti-inflammatories, and analgesics, crucial for effective disease management in different animal species. The robust distribution channels and established relationships with veterinary practitioners enhance their market penetration. In contrast, diagnostic kits are emerging as a significant segment, driven by technology advancements that enable rapid and accurate disease identification. These kits play a crucial role in proactive disease management and contribute to effective control measures in veterinary practices. Their growing demand aligns with an increasing focus on early detection and monitoring of diseases, positioning them as a key player in future veterinary healthcare.

Get more detailed insights about India Veterinary Medicine Manufacturing Market

Regional Insights

North America : Veterinary Innovation and Growth

The North American veterinary medicine market is driven by increasing pet ownership and a growing focus on animal health. The U.S. holds the largest market share at approximately 70%, followed by Canada at around 15%. Regulatory support from agencies like the FDA enhances product safety and efficacy, fostering innovation in veterinary pharmaceuticals. The rising trend of preventive healthcare for pets is also a significant growth driver, leading to increased demand for vaccines and diagnostics. Leading players in this region include Zoetis, Merck Animal Health, and Elanco Animal Health, which dominate the market with their extensive product portfolios. The competitive landscape is characterized by continuous R&D investments and strategic partnerships. The presence of advanced manufacturing facilities and a robust distribution network further strengthens the market position of these companies, ensuring a steady supply of veterinary medicines to meet the growing demand.

Europe : Regulatory Framework and Growth

The European veterinary medicine market is characterized by stringent regulations and a strong emphasis on animal welfare. Germany and France are the largest markets, holding approximately 25% and 20% of the market share, respectively. The European Medicines Agency (EMA) plays a crucial role in regulating veterinary products, ensuring safety and efficacy. The increasing awareness of zoonotic diseases and the need for preventive care are key drivers of market growth in this region. Countries like the UK, Italy, and Spain also contribute significantly to the market, with a competitive landscape featuring major players such as Boehringer Ingelheim and Virbac. The presence of local manufacturers like Hester Biosciences and Indian Immunologicals is also notable, as they cater to specific regional needs. The market is witnessing a trend towards biologics and advanced therapies, driven by innovation and research initiatives in veterinary medicine.

Asia-Pacific : Emerging Market Potential

The Asia-Pacific veterinary medicine market is experiencing rapid growth, driven by increasing livestock production and rising pet ownership. India and China are the largest markets, accounting for approximately 30% and 25% of the market share, respectively. The region's growth is supported by government initiatives aimed at improving animal health and food safety, alongside rising disposable incomes that enable pet owners to invest in veterinary care. Regulatory frameworks are evolving to support the introduction of innovative veterinary products. Countries like Japan and Australia also play significant roles in the market, with a competitive landscape featuring both global and local players. Key companies such as Zoetis and Merck Animal Health are expanding their presence in this region, while local firms like Hester Biosciences are gaining traction. The increasing focus on preventive healthcare and the development of new vaccines and treatments are expected to drive further growth in the veterinary sector across Asia-Pacific.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa veterinary medicine market is characterized by untapped potential and increasing demand for veterinary products. The region is witnessing a rise in livestock farming and pet ownership, with countries like South Africa and the UAE leading the market, holding approximately 20% and 15% of the market share, respectively. Government initiatives aimed at enhancing food security and animal health are driving growth, alongside increasing awareness of animal welfare and disease prevention. The competitive landscape includes both international and local players, with companies like Virbac and Indian Immunologicals making significant inroads. The presence of a diverse range of veterinary products, including pharmaceuticals and vaccines, is expanding. As the region continues to develop its veterinary infrastructure, the demand for innovative solutions is expected to rise, presenting opportunities for growth in the veterinary medicine sector.

India Veterinary Medicine Manufacturing Market Regional Image

Key Players and Competitive Insights

The Veterinary Medicine Market in India is characterized by a dynamic competitive landscape, driven by increasing pet ownership, rising awareness of animal health, and a growing demand for high-quality veterinary products. Major players such as Zoetis (IN), Boehringer Ingelheim (DE), and Merck Animal Health (US) are actively shaping the market through strategic initiatives focused on innovation and regional expansion. These companies are leveraging their extensive research and development capabilities to introduce advanced therapeutics and diagnostics, thereby enhancing their market positioning. The collective strategies of these firms contribute to a moderately fragmented market structure, where competition is intensifying as companies seek to differentiate themselves through product offerings and service excellence.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach not only enhances responsiveness to market demands but also aligns with the growing trend of sustainability in production processes. The competitive structure of the market remains moderately fragmented, with key players exerting considerable influence over pricing and product availability, thereby shaping the overall market dynamics.

In December 2025, Zoetis (IN) announced the launch of a new line of vaccines aimed at combating prevalent infectious diseases in livestock. This strategic move is significant as it addresses the urgent need for improved animal health solutions in the region, potentially increasing Zoetis's market share and reinforcing its commitment to innovation in veterinary medicine. The introduction of these vaccines is expected to enhance the health and productivity of livestock, thereby benefiting farmers and the agricultural sector at large.

In November 2025, Boehringer Ingelheim (DE) expanded its partnership with local veterinary clinics to enhance the distribution of its animal health products. This collaboration is pivotal as it allows for better access to Boehringer's innovative solutions, particularly in rural areas where veterinary services are often limited. By strengthening its distribution network, Boehringer Ingelheim is likely to improve its market penetration and customer engagement, which are crucial for sustaining competitive advantage.

In October 2025, Merck Animal Health (US) unveiled a digital platform designed to provide veterinarians with real-time data analytics and decision-making tools. This initiative reflects a broader trend towards digitalization in the veterinary sector, enabling practitioners to enhance their service delivery and improve patient outcomes. The integration of technology into veterinary practices is expected to become a key differentiator in the market, as companies that embrace digital solutions may gain a competitive edge.

As of January 2026, the Veterinary Medicine Market is witnessing a shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and service delivery. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, thereby redefining the parameters of success in this sector.

Key Companies in the India Veterinary Medicine Manufacturing Market include

Industry Developments

October 2022: To safeguard the nation from economically important illnesses such as foot and mouth disease (FMD) and other developing ailments, Hyderabad-based Indian Immunologicals Limited (IIL) announced that it will invest roughly Rs 700 Crores to establish a new animal vaccine manufacturing facility in Genome Valley, Hyderabad, known as the "Vaccine Hub of the World."

December 2021: Recently, A'alda Vet India Pvt. Ltd. and Fujifilm India Pvt. Ltd., a leader in medical imaging and diagnostic technology, partnered to improve pet healthcare facilities. As part of the collaboration, DCC (Dogs, Cats, and Companions) animals will receive cutting-edge medical and screening equipment from Fujifilm India.

Future Outlook

India Veterinary Medicine Manufacturing Market Future Outlook

The India Veterinary Medicine Market is projected to grow at a 5.1% CAGR from 2025 to 2035, driven by increasing pet ownership, advancements in veterinary technology, and rising awareness of animal health.

New opportunities lie in:

  • Development of telemedicine platforms for remote veterinary consultations.
  • Expansion of specialized veterinary pharmaceuticals targeting chronic diseases.
  • Investment in AI-driven diagnostic tools for early disease detection.

By 2035, the market is expected to be robust, reflecting significant advancements and growth.

Market Segmentation

India Veterinary Medicine Manufacturing Market Animal Type Outlook

  • Companion Animals
  • Livestock
  • Poultry
  • Aquaculture
  • Equine

India Veterinary Medicine Manufacturing Market Application Outlook

  • Therapeutic
  • Preventive
  • Diagnostic
  • Surgical
  • Nutritional

India Veterinary Medicine Manufacturing Market Product Type Outlook

  • Pharmaceuticals
  • Vaccines
  • Feed Additives
  • Medical Devices
  • Diagnostic Kits

Report Scope

MARKET SIZE 20241.81(USD Billion)
MARKET SIZE 20251.91(USD Billion)
MARKET SIZE 20353.13(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.1% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledZoetis (IN), Boehringer Ingelheim (DE), Merck Animal Health (US), Elanco Animal Health (US), Virbac (FR), Heska Corporation (US), Vetoquinol (FR), Indian Immunologicals Limited (IN), Patanjali Ayurved Limited (IN)
Segments CoveredApplication, Animal Type, Product Type
Key Market OpportunitiesGrowing demand for advanced veterinary pharmaceuticals driven by increasing pet ownership and livestock health awareness in India.
Key Market DynamicsRising demand for advanced veterinary therapeutics drives innovation and competition in India's veterinary medicine sector.
Countries CoveredIndia
Leave a Comment

FAQs

What is the current valuation of the India Veterinary Medicine Market?

<p>The market valuation was 1.81 USD Billion in 2024.</p>

What is the projected market size for the India Veterinary Medicine Market by 2035?

<p>The market is projected to reach 3.13 USD Billion by 2035.</p>

What is the expected CAGR for the India Veterinary Medicine Market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 5.1%.</p>

Which segments are included in the India Veterinary Medicine Market?

<p>The market segments include Therapeutic, Preventive, Diagnostic, Surgical, and Nutritional applications.</p>

How did the Therapeutic segment perform in 2024 compared to projections for 2035?

<p>The Therapeutic segment was valued at 0.72 USD Billion in 2024 and is projected to reach 1.23 USD Billion by 2035.</p>

What are the key animal types considered in the India Veterinary Medicine Market?

The key animal types include Companion Animals, Livestock, Poultry, Aquaculture, and Equine.

What was the valuation of the Companion Animals segment in 2024?

The Companion Animals segment was valued at 0.72 USD Billion in 2024.

Which companies are leading the India Veterinary Medicine Market?

Key players include Zoetis, Boehringer Ingelheim, Merck Animal Health, and Elanco Animal Health.

What is the projected growth for the Poultry segment by 2035?

The Poultry segment is expected to grow from 0.3 USD Billion in 2024 to 0.5 USD Billion by 2035.

What product types are included in the India Veterinary Medicine Market?

Product types include Pharmaceuticals, Vaccines, Feed Additives, Medical Devices, and Diagnostic Kits.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions